View abstract

This abstract is assigned to session AOB and FRO E-Posters

Title	Introducing Ruthenium Brachytherapy in UZ Leuven
Abstract Nr.	3015

Purpose	To introduce Ruthenium Brachytherapy at the UZ Leuven hospitals to improve the local treatment of uveal and conjunctival ocular tumors.
Methods	Ruthenium brachytherapy has been used for 3 decades now in European ocular oncology centers, to treat small and middle sized melanomas. Building on these experiences, we introduce this state-of-the-art treatment with local recurrence of 5% and limited radiation retinopathy.
Results	The implications for treatment of Ruthenium brachytherapy, with a longer hospital stay than Strontium brachytherapy, follow-up, and safety protocols will be discussed in the presentation.
Conclusion	Introducing Ruthenium brachytherapy in Belgium for the treatment of ocular tumors, expands the range of tumors that can be treated locally, with a minimum of complications.
Conflict of interest	No

Authors 1

Last name	MISSOTTEN
Initials	G
Department	Dept Ophthalmology, Catholic University Leuven
City	Leuven

Authors 2

Last name	Van Ginderdeuren
Initials	R
Department	Dept Ophthalmology, Catholic University Leuven
City	Leuven

Authors 3

Last name	Clément
Initials	P
Department	Dept Medical Oncology, Catholic University Leuven
City	Leuven

Authors 4

Last name	Vanden Bempt
Initials	I
Department	Dept Medical Genetics, Catholic University Leuven
City	Leuven

Authors 5

Last name	Van Limbergen
Initials	E
Department	Dept Radiotherapy, Catholic University Leuven
City	Leuven

Authors 6

Last name	Van Calster
Initials	J
Department	Dept Ophthalmology, Catholic University Leuven
City	Leuven